Top 100 Best Pharma Outsourcing Service Providers In China And India
This document was uploaded by user and they confirmed that they have the permission to share it. If you are author or own the copyright of this book, please report to us by using this DMCA report form. Report DMCA
Overview
Download & View Top 100 Best Pharma Outsourcing Service Providers In China And India as PDF for free.
More details
- Words: 1,281
- Pages: 6
中-印医药外 医药外包比较附 比较附录:
两国前50强 50强公司介绍 公司介绍
Top 100 100 Best Pharmaceutical Outsourcing Service Providers in China and India
Publisher: JZMed, Inc. July, 2009
JZMed, Inc.
About JZMed, Inc. JZMed, Inc. is a leading pharmaceutical outsourcing service provider that specializes in services for pharmaceutical and biotechnology industry. The company’s primary focus is to help Western pharmaceutical and biotech companies explore the opportunities in China, including tapping the Chinese pharmaceutical market and the resources available in Chinese pharmaceutical industry. Meanwhile, it also provides intelligence and market research services to these companies to facilitate their entrance into the Chinese pharmaceutical market or collaborations with any Chinese companies. The company has had opportunities to provide services to and collaborate with a variety of pharmaceutical and biotech companies worldwide that focus on drug discovery, development and/or manufacturing. It also has a network of preferred contract pharmaceutical research and manufacturing companies in China.
Report description It has been well recognized that the global pharmaceutical industry is facing a number of challenges at present. The difficulties the industry is experiencing have forced all drug companies to change their current operation models. They are now forced to pursue more efficient, cost-effective and productive ways to conduct their operations, whether in R&D or manufacturing. The keys for them to make a quick turnaround are to get drug discovered quicker, developed faster, manufactured cheaper and marketed wider. Outsourcing has been proven to be one of the effective solutions for drug companies to quickly turn the situation around as it provides them with the desired efficiency, flexibility and agility. Among all emerging countries for outsourcing, China and India have risen rapidly and become stars in the global pharmaceutical outsourcing arena as both countries possess the unique combination of low cost and quality service. The current global financial crisis has also greatly enhanced the importance of these two countries to many drug companies around the world who are vigorously seeking cost reduction. However, China and India each also possess their own, unique features and characteristics, not only in the pharmaceutical-related industries but also in almost every aspect of social structure. To many companies who are interested in conducting outsourcing or investment in either country, it is always a challenge to decide which country best fits their investment goals and which service provider in the selected country best fits the requirements of their projects. The report, “Top 100 Best Pharma Outsourcing Service Providers in China and India” (An appendix to the report “Comparison of Pharma Outsourcing between China and India”, which was separately published by JZMed, Inc.), compiled the detailed company profiles of top 100 best outsourcing service providers in both China and India. It equally selected, among a large pool of service vendors, 50 best players in each country. The report contains the most valuable and desirable information sought by all pharma and biotech companies who are interested in outsourcing to either China or India. After looking into the report, outsourcing companies will become comfortable directly approaching the interesting service providers in the selected country. The report will thus save them a preliminary trip to the country, which generally includes a team of company executives, before they start contacting the identified service providers. It will therefore save them a substantial amount of cost and time.
Selection criteria The top 50 best players in each country are carefully selected based on the following criteria. Each player must: 1) Be publicly recognized as a major player in their home country; or 2) Be one of the largest in company size and service revenue in the industry sector of their home country; or 3) Have long existing service history in the industry in their home country; or 4) Be most active in their industry sector; or 5) Have the broadest service scope and the strongest service capabilities in their industry sector; or 6) Be the best in special technical areas even though the company is not big and/or old enough in their industry sector.
Categories Examined for Each Service Provider For each selected best service provider in each country, the report examined a total of twelve technical categories (in addition to the detailed contact information) to comprehensively measure their service capabilities. These categories are considered the most important for an outsourcing company to know when it looks for a service provider in either China or India. These examined categories include: 1. Full description of each provider’s service scope; 2. Analysis and comments of their service features and strengths; 3. Evaluation of their service capability levels according to international pharma outsourcing standard; 4. Description of their facility and capacity; 5. In-house products that are ready to offer; 6. The number of technical employees including the percentage of senior level scientists; 7. Year the service company was founded; 8. Service experience and customers each provider has served so far; 9. Latest annual service revenues; 10. Background of service provider’s founder(s) or current executive(s) including their scientific/education merits and work experiences. 11. Overall rating of a service provider among all selected CROs and CMOs; 12. Latest business move/development.
Table of Contents Executive Summary Part I. Selection of Top 50 Best Service Providers in Each Country 1. Selection criteria 2. Classifications and definitions of CRO and CMO service capability levels 3. Classifications and ratings of CROs and CMOs Part II. Company Profiles of Top 50 Best Chinese Outsourcing Service Providers Part III. Company Profiles of Top 50 Best Indian Outsourcing Service Providers Part IV. Classifications of All 100 Best Service Providers in China and India 1. List of top pharma companies in China and India 2. List of top biotech companies in China and India 3. List of top CROs in China and India 4. List of top CMOs in China and India 5. List of top API and generic drug makers in China and India 6. List of Chinese and Indian companies with Level 5 service capability 7. List of Chinese and Indian companies with Level 4 service capability 8. List of Chinese and Indian companies with Level 3 service capability 9. List of top CROs in China and India for drug discovery service 10. List of top CROs in China and India for process R&D 11. List of top CROs in China and India for medicinal chemistry research 12. List of top CROs in China and India for preclinical research service 13. List of top CROs in China and India for ADME/Tox study 14. List of top CROs in China and India having non-human primate animal testing facilities 15. List of top CROs in China and India for clinical research service 16. List of top CROs in China and India having central lab service 17. List of top CROs in China and India in genomics and proteomics research 18. List of top Chinese and Indian pharma companies having internal R&D programs 19. List of top Chinese and Indian pharma companies having drug candidates in late development stages 20. List of top Chinese and Indian pharma companies having products marketed globally 21. List of top Chinese and Indian pharma companies having global presences Appendix About JZMed, Inc.
To Order
Information about the Report: Publisher: JZMed, Inc. Numbers of outsourcing service providers included: 100 best players in China and India; Top 50 best players in China; Top 50 best players in India. Total number of pages: 189 Date published: July, 2009
Price Information: For single user: $945/PDF copy; $1,045/hard copy For department licensing: $1,890 (PDF copy only) For enterprise-wide licensing: $2,835 (PDF copy only)
Readers interested in the report can contact JZMed, Inc. at [email protected]. Report ordering can also be processed through Paypal, secured online payment, directly at the website of JZMed, Inc. (www.jzmedi.com). All major credit cards are accepted.
两国前50强 50强公司介绍 公司介绍
Top 100 100 Best Pharmaceutical Outsourcing Service Providers in China and India
Publisher: JZMed, Inc. July, 2009
JZMed, Inc.
About JZMed, Inc. JZMed, Inc. is a leading pharmaceutical outsourcing service provider that specializes in services for pharmaceutical and biotechnology industry. The company’s primary focus is to help Western pharmaceutical and biotech companies explore the opportunities in China, including tapping the Chinese pharmaceutical market and the resources available in Chinese pharmaceutical industry. Meanwhile, it also provides intelligence and market research services to these companies to facilitate their entrance into the Chinese pharmaceutical market or collaborations with any Chinese companies. The company has had opportunities to provide services to and collaborate with a variety of pharmaceutical and biotech companies worldwide that focus on drug discovery, development and/or manufacturing. It also has a network of preferred contract pharmaceutical research and manufacturing companies in China.
Report description It has been well recognized that the global pharmaceutical industry is facing a number of challenges at present. The difficulties the industry is experiencing have forced all drug companies to change their current operation models. They are now forced to pursue more efficient, cost-effective and productive ways to conduct their operations, whether in R&D or manufacturing. The keys for them to make a quick turnaround are to get drug discovered quicker, developed faster, manufactured cheaper and marketed wider. Outsourcing has been proven to be one of the effective solutions for drug companies to quickly turn the situation around as it provides them with the desired efficiency, flexibility and agility. Among all emerging countries for outsourcing, China and India have risen rapidly and become stars in the global pharmaceutical outsourcing arena as both countries possess the unique combination of low cost and quality service. The current global financial crisis has also greatly enhanced the importance of these two countries to many drug companies around the world who are vigorously seeking cost reduction. However, China and India each also possess their own, unique features and characteristics, not only in the pharmaceutical-related industries but also in almost every aspect of social structure. To many companies who are interested in conducting outsourcing or investment in either country, it is always a challenge to decide which country best fits their investment goals and which service provider in the selected country best fits the requirements of their projects. The report, “Top 100 Best Pharma Outsourcing Service Providers in China and India” (An appendix to the report “Comparison of Pharma Outsourcing between China and India”, which was separately published by JZMed, Inc.), compiled the detailed company profiles of top 100 best outsourcing service providers in both China and India. It equally selected, among a large pool of service vendors, 50 best players in each country. The report contains the most valuable and desirable information sought by all pharma and biotech companies who are interested in outsourcing to either China or India. After looking into the report, outsourcing companies will become comfortable directly approaching the interesting service providers in the selected country. The report will thus save them a preliminary trip to the country, which generally includes a team of company executives, before they start contacting the identified service providers. It will therefore save them a substantial amount of cost and time.
Selection criteria The top 50 best players in each country are carefully selected based on the following criteria. Each player must: 1) Be publicly recognized as a major player in their home country; or 2) Be one of the largest in company size and service revenue in the industry sector of their home country; or 3) Have long existing service history in the industry in their home country; or 4) Be most active in their industry sector; or 5) Have the broadest service scope and the strongest service capabilities in their industry sector; or 6) Be the best in special technical areas even though the company is not big and/or old enough in their industry sector.
Categories Examined for Each Service Provider For each selected best service provider in each country, the report examined a total of twelve technical categories (in addition to the detailed contact information) to comprehensively measure their service capabilities. These categories are considered the most important for an outsourcing company to know when it looks for a service provider in either China or India. These examined categories include: 1. Full description of each provider’s service scope; 2. Analysis and comments of their service features and strengths; 3. Evaluation of their service capability levels according to international pharma outsourcing standard; 4. Description of their facility and capacity; 5. In-house products that are ready to offer; 6. The number of technical employees including the percentage of senior level scientists; 7. Year the service company was founded; 8. Service experience and customers each provider has served so far; 9. Latest annual service revenues; 10. Background of service provider’s founder(s) or current executive(s) including their scientific/education merits and work experiences. 11. Overall rating of a service provider among all selected CROs and CMOs; 12. Latest business move/development.
Table of Contents Executive Summary Part I. Selection of Top 50 Best Service Providers in Each Country 1. Selection criteria 2. Classifications and definitions of CRO and CMO service capability levels 3. Classifications and ratings of CROs and CMOs Part II. Company Profiles of Top 50 Best Chinese Outsourcing Service Providers Part III. Company Profiles of Top 50 Best Indian Outsourcing Service Providers Part IV. Classifications of All 100 Best Service Providers in China and India 1. List of top pharma companies in China and India 2. List of top biotech companies in China and India 3. List of top CROs in China and India 4. List of top CMOs in China and India 5. List of top API and generic drug makers in China and India 6. List of Chinese and Indian companies with Level 5 service capability 7. List of Chinese and Indian companies with Level 4 service capability 8. List of Chinese and Indian companies with Level 3 service capability 9. List of top CROs in China and India for drug discovery service 10. List of top CROs in China and India for process R&D 11. List of top CROs in China and India for medicinal chemistry research 12. List of top CROs in China and India for preclinical research service 13. List of top CROs in China and India for ADME/Tox study 14. List of top CROs in China and India having non-human primate animal testing facilities 15. List of top CROs in China and India for clinical research service 16. List of top CROs in China and India having central lab service 17. List of top CROs in China and India in genomics and proteomics research 18. List of top Chinese and Indian pharma companies having internal R&D programs 19. List of top Chinese and Indian pharma companies having drug candidates in late development stages 20. List of top Chinese and Indian pharma companies having products marketed globally 21. List of top Chinese and Indian pharma companies having global presences Appendix About JZMed, Inc.
To Order
Information about the Report: Publisher: JZMed, Inc. Numbers of outsourcing service providers included: 100 best players in China and India; Top 50 best players in China; Top 50 best players in India. Total number of pages: 189 Date published: July, 2009
Price Information: For single user: $945/PDF copy; $1,045/hard copy For department licensing: $1,890 (PDF copy only) For enterprise-wide licensing: $2,835 (PDF copy only)
Readers interested in the report can contact JZMed, Inc. at [email protected]. Report ordering can also be processed through Paypal, secured online payment, directly at the website of JZMed, Inc. (www.jzmedi.com). All major credit cards are accepted.
Related Documents
Top10 Service Outsourcing 20 Parks In China
June 2020 6
Current Development State Of China Pharma Outsourcing
December 2019 0